Exact Mass: 525.2573834
Exact Mass Matches: 525.2573834
Found 251 metabolites which its exact mass value is equals to given mass value 525.2573834
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Mikamycin A
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D025361 - Streptogramins Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by?Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL. The combination of Virginiamycin M1 and Virginiamycin S1 (HY-N6680) is 0.125 μg/mL (MIC Value), which can improve the bactericidal effect 1-30 times[2].
virginiamycin m1
Selpercatinib
Chondrochloren A
C27H40ClNO7 (525.2493160000001)
A monocarboxylic acid amide with formula C27H40ClNO7, that is produced by Chondromyces crocatus and exhibits antibiotic properties.
His Val Arg Asp
Cys Ile Lys Tyr
Cys Ile Tyr Lys
Cys Lys Ile Tyr
Cys Lys Leu Tyr
Cys Lys Tyr Ile
Cys Lys Tyr Leu
Cys Leu Lys Tyr
Cys Leu Tyr Lys
Cys Tyr Ile Lys
Cys Tyr Lys Ile
Cys Tyr Lys Leu
Cys Tyr Leu Lys
Asp His Arg Val
Asp His Val Arg
Asp Arg His Val
Asp Arg Val His
Asp Val His Arg
Asp Val Arg His
Glu His Ile Gln
C22H35N7O8 (525.2546990000001)
Glu His Leu Gln
C22H35N7O8 (525.2546990000001)
Glu His Gln Ile
C22H35N7O8 (525.2546990000001)
Glu His Gln Leu
C22H35N7O8 (525.2546990000001)
Glu Ile His Gln
C22H35N7O8 (525.2546990000001)
Glu Ile Gln His
C22H35N7O8 (525.2546990000001)
Glu Leu His Gln
C22H35N7O8 (525.2546990000001)
Glu Leu Gln His
C22H35N7O8 (525.2546990000001)
Glu Gln His Ile
C22H35N7O8 (525.2546990000001)
Glu Gln His Leu
C22H35N7O8 (525.2546990000001)
Glu Gln Ile His
C22H35N7O8 (525.2546990000001)
Glu Gln Leu His
C22H35N7O8 (525.2546990000001)
Phe Phe Asn Val
Phe Phe Val Asn
Phe Lys Met Thr
Phe Lys Thr Met
Phe Met Lys Thr
Phe Met Thr Lys
Phe Asn Phe Val
Phe Asn Val Phe
Phe Thr Lys Met
Phe Thr Met Lys
Phe Val Phe Asn
Phe Val Asn Phe
His Asp Arg Val
His Asp Val Arg
His Glu Ile Gln
C22H35N7O8 (525.2546990000001)
His Glu Leu Gln
C22H35N7O8 (525.2546990000001)
His Glu Gln Ile
C22H35N7O8 (525.2546990000001)
His Glu Gln Leu
C22H35N7O8 (525.2546990000001)
His Ile Glu Gln
C22H35N7O8 (525.2546990000001)
His Ile Gln Glu
C22H35N7O8 (525.2546990000001)
His Lys Asn Gln
His Lys Gln Asn
His Leu Glu Gln
C22H35N7O8 (525.2546990000001)
His Leu Gln Glu
C22H35N7O8 (525.2546990000001)
His Asn Lys Gln
His Asn Gln Lys
His Gln Glu Ile
C22H35N7O8 (525.2546990000001)
His Gln Glu Leu
C22H35N7O8 (525.2546990000001)
His Gln Ile Glu
C22H35N7O8 (525.2546990000001)
His Gln Lys Asn
His Gln Leu Glu
C22H35N7O8 (525.2546990000001)
His Gln Asn Lys
His Arg Asp Val
His Arg Val Asp
His Val Asp Arg
Ile Cys Lys Tyr
Ile Cys Tyr Lys
Ile Glu His Gln
C22H35N7O8 (525.2546990000001)
Ile Glu Gln His
C22H35N7O8 (525.2546990000001)
Ile His Glu Gln
C22H35N7O8 (525.2546990000001)
Ile His Gln Glu
C22H35N7O8 (525.2546990000001)
Ile Lys Cys Tyr
Ile Lys Tyr Cys
Ile Gln Glu His
C22H35N7O8 (525.2546990000001)
Ile Gln His Glu
C22H35N7O8 (525.2546990000001)
Ile Tyr Cys Lys
Ile Tyr Lys Cys
Lys Cys Ile Tyr
Lys Cys Leu Tyr
Lys Cys Tyr Ile
Lys Cys Tyr Leu
Lys Phe Met Thr
Lys Phe Thr Met
Lys His Asn Gln
Lys His Gln Asn
Lys Ile Cys Tyr
Lys Ile Tyr Cys
Lys Leu Cys Tyr
Lys Leu Tyr Cys
Lys Met Phe Thr
Lys Met Thr Phe
Lys Asn His Gln
Lys Asn Gln His
Lys Gln His Asn
Lys Gln Asn His
Lys Thr Phe Met
Lys Thr Met Phe
Lys Tyr Cys Ile
Lys Tyr Cys Leu
Lys Tyr Ile Cys
Lys Tyr Leu Cys
Leu Cys Lys Tyr
Leu Cys Tyr Lys
Leu Glu His Gln
C22H35N7O8 (525.2546990000001)
Leu Glu Gln His
C22H35N7O8 (525.2546990000001)
Leu His Glu Gln
C22H35N7O8 (525.2546990000001)
Leu His Gln Glu
C22H35N7O8 (525.2546990000001)
Leu Lys Cys Tyr
Leu Lys Tyr Cys
Leu Gln Glu His
C22H35N7O8 (525.2546990000001)
Leu Gln His Glu
C22H35N7O8 (525.2546990000001)
Leu Tyr Cys Lys
Leu Tyr Lys Cys
Met Phe Lys Thr
Met Phe Thr Lys
Met Lys Phe Thr
Met Lys Thr Phe
Met Thr Phe Lys
Met Thr Lys Phe
Asn Phe Phe Val
Asn Phe Val Phe
Asn His Lys Gln
Asn His Gln Lys
Asn Lys His Gln
Asn Lys Gln His
Asn Gln His Lys
Asn Gln Lys His
Asn Val Phe Phe
Gln Glu His Ile
C22H35N7O8 (525.2546990000001)
Gln Glu His Leu
C22H35N7O8 (525.2546990000001)
Gln Glu Ile His
C22H35N7O8 (525.2546990000001)
Gln Glu Leu His
C22H35N7O8 (525.2546990000001)
Gln His Glu Ile
C22H35N7O8 (525.2546990000001)
Gln His Glu Leu
C22H35N7O8 (525.2546990000001)
Gln His Ile Glu
C22H35N7O8 (525.2546990000001)
Gln His Lys Asn
Gln His Leu Glu
C22H35N7O8 (525.2546990000001)
Gln His Asn Lys
Gln Ile Glu His
C22H35N7O8 (525.2546990000001)
Gln Ile His Glu
C22H35N7O8 (525.2546990000001)
Gln Lys His Asn
Gln Lys Asn His
Gln Leu Glu His
C22H35N7O8 (525.2546990000001)
Gln Leu His Glu
C22H35N7O8 (525.2546990000001)
Gln Asn His Lys
Gln Asn Lys His
Arg Asp His Val
Arg Asp Val His
Arg His Asp Val
Arg His Val Asp
Arg Ser Thr Tyr
C22H35N7O8 (525.2546990000001)
Arg Ser Tyr Thr
C22H35N7O8 (525.2546990000001)
Arg Thr Ser Tyr
C22H35N7O8 (525.2546990000001)
Arg Thr Tyr Ser
C22H35N7O8 (525.2546990000001)
Arg Val Asp His
Arg Val His Asp
Arg Tyr Ser Thr
C22H35N7O8 (525.2546990000001)
Arg Tyr Thr Ser
C22H35N7O8 (525.2546990000001)
Ser Arg Thr Tyr
C22H35N7O8 (525.2546990000001)
Ser Arg Tyr Thr
C22H35N7O8 (525.2546990000001)
Ser Thr Arg Tyr
C22H35N7O8 (525.2546990000001)
Ser Thr Tyr Arg
C22H35N7O8 (525.2546990000001)
Ser Tyr Arg Thr
C22H35N7O8 (525.2546990000001)
Ser Tyr Thr Arg
C22H35N7O8 (525.2546990000001)
Thr Phe Lys Met
Thr Phe Met Lys
Thr Lys Phe Met
Thr Lys Met Phe
Thr Met Phe Lys
Thr Met Lys Phe
Thr Arg Ser Tyr
C22H35N7O8 (525.2546990000001)
Thr Arg Tyr Ser
C22H35N7O8 (525.2546990000001)
Thr Ser Arg Tyr
C22H35N7O8 (525.2546990000001)
Thr Ser Tyr Arg
C22H35N7O8 (525.2546990000001)
Thr Tyr Arg Ser
C22H35N7O8 (525.2546990000001)
Thr Tyr Ser Arg
C22H35N7O8 (525.2546990000001)
Val Asp His Arg
Val Asp Arg His
Val Phe Phe Asn
Val Phe Asn Phe
Val His Asp Arg
Val His Arg Asp
Val Asn Phe Phe
Val Arg Asp His
Val Arg His Asp
Tyr Cys Ile Lys
Tyr Cys Lys Ile
Tyr Cys Lys Leu
Tyr Cys Leu Lys
Tyr Ile Cys Lys
Tyr Ile Lys Cys
Tyr Lys Cys Ile
Tyr Lys Cys Leu
Tyr Lys Ile Cys
Tyr Lys Leu Cys
Tyr Leu Cys Lys
Tyr Leu Lys Cys
Tyr Arg Ser Thr
C22H35N7O8 (525.2546990000001)
Tyr Arg Thr Ser
C22H35N7O8 (525.2546990000001)
Tyr Ser Arg Thr
C22H35N7O8 (525.2546990000001)
Tyr Ser Thr Arg
C22H35N7O8 (525.2546990000001)
Tyr Thr Arg Ser
C22H35N7O8 (525.2546990000001)
Tyr Thr Ser Arg
C22H35N7O8 (525.2546990000001)
Pentoxyverine Citrate
C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) citrate is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membrane σ1, respectively. Pentoxyverine citrate is a muscarinic antagonist. Pentoxyverine citrate is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine citrate can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].
N2-[(Phenylmethyl)sulfonyl]-D-arginyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]glycinamide
C21H35N9O5S (525.2481740000001)
Flovagatran
C27H36BN3O7 (525.2646176000001)
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
Selpercatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Virginiamycin M1
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D025361 - Streptogramins C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by?Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL. The combination of Virginiamycin M1 and Virginiamycin S1 (HY-N6680) is 0.125 μg/mL (MIC Value), which can improve the bactericidal effect 1-30 times[2].
[(1-{2[(4-Carbamimidoyl-phenylamino)-methyl]-1-methyl-1H-benzoimidazol-5-YL}-cyclopropyl)-pyridin-2-YL-methyleneaminooxy]-acetic acid ethyl ester
(E,3R,8S,9S,10R)-N-[(Z)-2-(3-chloro-4-hydroxyphenyl)ethenyl]-3,9-dihydroxy-2,4-dimethoxy-6,8,10-trimethyl-7-oxotetradec-5-enamide
C27H40ClNO7 (525.2493160000001)
N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]-4-[(3,5-dimethyl-4-isoxazolyl)methoxy]-3-methoxybenzamide
N-[(2S,4aR,12aR)-2-[2-[(1,3-dimethylpyrazol-4-yl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(5R,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(2S,4aR,12aS)-2-[2-[(1,3-dimethylpyrazol-4-yl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(5R,6S,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(2R,4aR,12aS)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(5S,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(5S,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(5S,6S,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(5R,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(2S,4aS,12aS)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aS,12aR)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aR,12aR)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aS,12aR)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aS,12aS)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
Pristinamycin IIA
A macrolide that is (together with pristinamycin IA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus.
3,9-dihydroxy-5-(1h-indol-3-ylmethyl)-7,8,14,16-tetramethyl-22-oxa-4,21-diazapentacyclo[16.2.1.1⁵,⁸.0²,⁶.0²,¹⁰]docosa-1(20),3,11,15,18-pentaen-17-one
(10s,11s,12e,17e,19e,21r)-14,21-dihydroxy-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0³,⁷]octacosa-1(27),6,12,14,17,19,25(28)-heptaene-2,8,23-trione
n-[2-(3-chloro-4-hydroxyphenyl)ethenyl]-3,9-dihydroxy-2,4-dimethoxy-6,8,10-trimethyl-7-oxotetradec-5-enimidic acid
C27H40ClNO7 (525.2493160000001)
(10r,11r,12e,17e,19e,21s)-14,21-dihydroxy-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0³,⁷]octacosa-1(27),6,12,14,17,19,25(28)-heptaene-2,8,23-trione
(9r,14s,17s,23r,24s)-23,24-dihydroxy-5-methoxy-9,12,12-trimethyl-9-(2-methylprop-1-en-1-yl)-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.0²,⁷.0⁸,²⁵.0¹⁵,²³.0¹⁷,²¹]pentacosa-1(25),2,4,6-tetraene-16,22-dione
(2s,5r,6r,7s,8s,9s,10r,14s)-3,9-dihydroxy-5-(1h-indol-3-ylmethyl)-7,8,14,16-tetramethyl-22-oxa-4,21-diazapentacyclo[16.2.1.1⁵,⁸.0²,⁶.0²,¹⁰]docosa-1(20),3,11,15,18-pentaen-17-one
23,24-dihydroxy-5-methoxy-9,12,12-trimethyl-9-(2-methylprop-1-en-1-yl)-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.0²,⁷.0⁸,²⁵.0¹⁵,²³.0¹⁷,²¹]pentacosa-1(25),2,4,6-tetraene-16,22-dione
(12z,17z,19z)-14,21-dihydroxy-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0³,⁷]octacosa-1(27),6,12,14,17,19,25(28)-heptaene-2,8,23-trione
(10r,11r,12z,17z,19z,21s)-14,21-dihydroxy-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0³,⁷]octacosa-1(27),6,12,14,17,19,25(28)-heptaene-2,8,23-trione
(2r,3r,4r,5e,8s,9s,10r)-n-[(1z)-2-(3-chloro-4-hydroxyphenyl)ethenyl]-3,9-dihydroxy-2,4-dimethoxy-6,8,10-trimethyl-7-oxotetradec-5-enimidic acid
C27H40ClNO7 (525.2493160000001)